Shenzhen Edge Medical FY26 H1 net loss narrows 78.4% to RMB 19.25 million; revenue more than doubled to RMB 319.32 million

PUBT · 1d ago
Shenzhen Edge Medical FY26 H1 net loss narrows 78.4% to RMB 19.25 million; revenue more than doubled to RMB 319.32 million
  • Shenzhen Edge Medical posted revenue of RMB 319.32 million for H1 2026, more than doubled by 113.8% year over year.
  • Loss attributable to equity shareholders narrowed to RMB 19.25 million, improving 78.4% from a year earlier.
  • Gross profit climbed to RMB 204.63 million, rising 118%; gross margin widened 1.3 percentage points to 64.1%.
  • Overseas end-user product revenue reached RMB 222.8 million, representing about 69.8% of total revenue.
  • Global installations or deliveries totaled 58 units; cash and cash equivalents rose to RMB 1.26 billion following January’s global offering.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shenzhen Edge Medical Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260828-12307104), on August 28, 2026, and is solely responsible for the information contained therein.